Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
Carfilzomib (PR-171) Cancer Research Workflow
2026-09-03
Build a more informative Carfilzomib workflow by pairing direct proteasome activity measurements with proteotoxic-stress and cell-death readouts. The approach also shows how PR-171 can support dose-optimization studies alongside epigenetic or protein-folding interventions without confusing mechanistic rationale with direct combination evidence.
-
Poly(I:C) and the Hidden Logic of dsRNA Sensing
2026-09-03
Poly (I:C), a synthetic double-stranded RNA analog and TLR3 agonist, is more than a robust interferon inducer. This thought-leadership guide connects route-aware innate immune response stimulation with new findings on Junctophilin-2, MDA5, and cardiomyocyte biology, offering translational researchers a framework for better assay design and interpretation.
-
MLN4924: NEDD8-Activating Enzyme Inhibitor
2026-09-02
MLN4924 is a selective NEDD8-activating enzyme inhibitor that suppresses neddylation and cullin-RING ligase activity. Its reported 4 nM enzyme potency, pathway-level biomarkers, and xenograft activity make it a useful tool for cancer biology research, while its enzyme-to-cell translation requires system-specific validation.
-
SFI Inhibits Glioma via SRC/PI3K/AKT Signaling
2026-09-02
The reference study combines network pharmacology with cellular and mouse experiments to identify the SRC/PI3K/AKT pathway as a central mechanism of Shenqi Fuzheng injection activity in glioma. Its findings connect computational target prioritization with evidence for reduced proliferation, migration, cell-cycle progression, and tumor development.
-
Reactive Oxygen Species Assay Kit: DHE & Caspase-1
2026-09-01
Learn how the Reactive Oxygen Species Assay Kit and dihydroethidium (DHE) probe can place intracellular superoxide within a mechanistic oxidative-stress workflow. This guide interprets DHE fluorescence alongside caspase-1, cytokine, and cell-death measurements in mycotoxin immunotoxicity research.
-
Ziprasidone HCl: Applied Research Workflows
2026-09-01
Ziprasidone HCl supports two distinct research tracks: receptor-focused neuroscience experiments and GOT1-linked cancer metabolism studies. This workflow guide translates quantitative benchmarks into practical cell, enzyme, permeability, and formulation assays while separating established findings from exploratory recommendations.
-
CUDC-907 Protocol and QC Guide
2026-08-31
CUDC-907 is a dual PI3K and HDAC inhibitor for coordinated study of PI3K/AKT signaling, histone deacetylase activity, cell-cycle progression, and apoptosis in cancer-cell models. This dossier-based guidance supports controlled in vitro research only; it does not establish diagnostic, therapeutic, or clinical use.
-
BCECF-AM for Plant Autophagy pH Analysis
2026-08-31
BCECF-AM enables ratiometric intracellular pH measurement while providing a functional lens on vacuolar acidification in Arabidopsis autophagy. This article connects dye chemistry with SINAT–VAB1 biology, emphasizing assay interpretation, controls, and compartment-specific limitations.
-
RHEB Neddylation Activates mTORC1 in Liver Cancer
2026-08-30
The reference study identifies RHEB as a non-cullin substrate of the UBE2F–SAG neddylation axis and shows that modification at K169 strengthens lysosomal localization, GTP binding, and mTORC1 signaling. Genetic and disease-model data connect this mechanism to liver steatosis, hepatocellular carcinoma, and patient survival, while also defining important limits for therapeutic translation.
-
DDM: From Membrane Solubilization to Drug Discovery
2026-08-29
Membrane proteins are difficult not because they lack biological importance, but because purification can disrupt the very lipid-dependent states researchers need to measure. This thought-leadership article explains how n-Dodecyl-β-D-maltoside, or DDM, can support a disciplined WecA workflow while clarifying its limits, assay controls, and translational value for anti-tuberculosis discovery.
-
Sulforaphane: From Redox Signal to Assay Design
2026-08-28
Sulforaphane research is moving from single-endpoint measurements toward causal, multi-readout assay design. This guide connects Keap1–Nrf2 signaling with NLRP3 regulation, cell-cycle control, and practical workflows for cancer chemoprevention and oxidative stress response studies.
-
A 83-01 ALK-5 Inhibitor Workflow
2026-08-28
Build cleaner TGF-β experiments with A 83-01, from receptor-level pathway inhibition to fibrosis, EMT, and organoid assays. This practical guide combines concentration planning, orthogonal readouts, and troubleshooting for more reproducible Smad-dependent transcription suppression.
-
Tetraethylammonium Chloride: A Mechanistic Guide
2026-08-27
Tetraethylammonium chloride (TEAC) is more than a conventional potassium-channel blocker: it is a mechanistic perturbation tool for separating ion-conduction effects from receptor and tissue-level responses. This guide connects pore blockade, orthogonal assay design, β-cell physiology, vascular research, and practical product handling.
-
Annexin V-FITC/PI Apoptosis Assay Kit Guide
2026-08-27
The Annexin V-FITC/PI Apoptosis Assay Kit (SKU K2003) helps researchers distinguish viable, early apoptotic, and membrane-compromised cells using phosphatidylserine binding and PI exclusion. It is intended for research workflows using flow cytometry or fluorescence microscopy, not clinical diagnosis, treatment decisions, or regulatory testing.
-
L-Glutathione Reduced in Redox Assay Design
2026-08-26
L-Glutathione Reduced connects thiol redox chemistry with practical cancer-metabolism assay design. This evidence-based guide explains how to use reduced glutathione as a controlled reagent, interpret oxidative stress biomarker data, and complement GOT1-focused experiments without overclaiming mechanism.